Hi Rorbag - cap raise assessment was back of the envelope... Costs approx $8M pa. AAR currently $1.8M and predicted to go to a maximum of $4.2M by "early 2023". So approx a $4M shortfall with $6.9M in the bank. Need to double the assumed AAR revenue of $4.2M to cover costs to be sustainable. So they have 5 to 6 quarters to do this to avoid another cap raise. Not an insignificant task - but lots of irons in the fire
Risks are:
Cost base increase due to international expansion, infant app launch, FDA approval?
Slower rate of implementation of current licences
Poor conversion of the $2M AAR govt funded beds to commercial contracts. Hard to believe there is still 12,870 beds ($0.5M) that were govt funded but not yet implemented
I'm slightly more optimistic than Fattchoi & Screenlover and reckon PCK will be revenue neutral in 2024 rather than 2025 - but have been wrong before!!! Also believe/hopeful that there should be healthy SP growth over this time
Saw Portugal but not Brazil or Canada - but use the free version of APPlyzer
PCK Price at posting:
3.8¢ Sentiment: Buy Disclosure: Held
- but have been wrong before!!! Also believe/hopeful that there should be healthy SP growth over this time
